Sorafenib may improve response rate and progression-free survival (PFS) duration in patients with iodine refractory thyroid cancer

By  

Inpharma, Vol. 1, Iss. 1647, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer

By Akay Catherine L.   Ueno Naoto T.   Chisholm Gary B.   Hortobagyi Gabriel N.   Woodward Wendy A.   Alvarez Ricardo H.   Bedrosian Isabelle   Kuerer Henry M.   Hunt Kelly K.   Huo Lei   Babiera Gildy V.  

Cancer, Vol. 120, Iss. 9, 2014-05 ,pp. : 1319-1328

Blackwell Publishing

Access to resources Recommend Favorite

APC 8015 may improve survival duration in prostate cancer

By  

Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community

By Penn Dolly C.   Chang YunKyung   Meyer Anne-Marie   DeFilippo Mack Christina   Sanoff Hanna K.   Stitzenberg Karyn B.   Carpenter William R.  

Cancer, Vol. 121, Iss. 1, 2015-01 ,pp. : 93-101

Blackwell Publishing

Access to resources Recommend Favorite

First-Line Treatment Strategies to Improve Survival in Patients with Advanced Colorectal Cancer

By Gill S.  

Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. : 27-44

Adis International

Access to resources Recommend Favorite